http://rdf.ncbi.nlm.nih.gov/pubchem/patent/SE-8401398-D0

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_76195fd1cd08192222699d8e7a88c231
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D493-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C405-0025
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D493-08
filingDate 1984-03-13-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7670f6872db88a86874a95ea35f7d974
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7c7c4d985dc339ff4f30050827b723b5
publicationDate 1984-03-13-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber SE-8401398-D0
titleOfInvention 7-OXABICYCLOHEPTAN SUBSTITUTED PROSTAGLANDIN ANALOGS
abstract 7-Oxabicycloheptane substituted prostaglandin analogs are provided having the structural formula <IMAGE> wherein B is oxygen (-O-) or <IMAGE> wherein n' is 0 to 2, R is hydrogen, lower alkyl, alkali metal or trihydroxymethylaminomethane, R<1> is alkyl, alkenyl, alkynyl, aryl, aralkyl, aralkenyl, aralkynyl, cycloalkylalkyl, cycloalkylalkenyl or cycloalkynyl. A is -CH=CH- or -(CH2)2-, n is 1 to 4, and m is 1 to 8, and including all stereoisomers thereof. The compounds are cardiovascular agents useful, for example, in the treatment of thrombolytic disease.
priorityDate 1983-03-14-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID18675856
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9877341
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID977
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419523291
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID414810016
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID421330040

Total number of triples: 19.